Boston Scientific Corp (BSX)
68.99
+0.97
(+1.43%)
USD |
NYSE |
Apr 23, 16:00
69.98
+0.99
(+1.43%)
Pre-Market: 20:00
Boston Scientific Cash from Investing (TTM): -2.574B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.574B |
| September 30, 2023 | -1.704B |
| June 30, 2023 | -1.732B |
| March 31, 2023 | -921.00M |
| December 31, 2022 | -2.011B |
| September 30, 2022 | -2.289B |
| June 30, 2022 | -3.271B |
| March 31, 2022 | -3.242B |
| December 31, 2021 | -1.597B |
| September 30, 2021 | -1.283B |
| June 30, 2021 | -205.00M |
| March 31, 2021 | -264.00M |
| December 31, 2020 | -411.00M |
| September 30, 2020 | -313.00M |
| June 30, 2020 | -4.146B |
| March 31, 2020 | -4.707B |
| December 31, 2019 | -5.041B |
| September 30, 2019 | -5.587B |
| June 30, 2019 | -2.287B |
| March 31, 2019 | -2.158B |
| December 31, 2018 | -1.921B |
| September 30, 2018 | -1.615B |
| June 30, 2018 | -1.055B |
| March 31, 2018 | -1.043B |
| December 31, 2017 | -1.01B |
| Date | Value |
|---|---|
| September 30, 2017 | -1.253B |
| June 30, 2017 | -1.356B |
| March 31, 2017 | -979.00M |
| December 31, 2016 | -887.00M |
| September 30, 2016 | -525.00M |
| June 30, 2016 | -2.039B |
| March 31, 2016 | -2.183B |
| December 31, 2015 | -2.186B |
| September 30, 2015 | -2.099B |
| June 30, 2015 | -853.00M |
| March 31, 2015 | -731.00M |
| December 31, 2014 | -745.00M |
| September 30, 2014 | -1.025B |
| June 30, 2014 | -625.00M |
| March 31, 2014 | -529.00M |
| December 31, 2013 | -475.00M |
| September 30, 2013 | -385.00M |
| June 30, 2013 | -365.00M |
| March 31, 2013 | -524.00M |
| December 31, 2012 | -579.00M |
| September 30, 2012 | -357.00M |
| June 30, 2012 | -363.00M |
| March 31, 2012 | -258.00M |
| December 31, 2011 | 776.00M |
| September 30, 2011 | 576.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.587B
Minimum
Sep 2019
-205.00M
Maximum
Jun 2021
-2.294B
Average
-2.011B
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| Stryker Corp | -962.00M |
| Abbott Laboratories | -3.133B |
| Edwards Lifesciences Corp | 173.80M |
| Intuitive Surgical Inc | -1.062B |
| Axonics Inc | -116.90M |